Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
about
Activity of polymorphonuclear leukocytes in the presence of sulfideStimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.Capsular sialic acid limits C5a production on type III group B streptococci.Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis.Role of adherence in the pathogenesis of neonatal group B streptococcal infection.Critical role of the complement system in group B streptococcus-induced tumor necrosis factor alpha release.The Group B Streptococcus-Secreted Protein CIP Interacts with C4, Preventing C3b Deposition via the Lectin and Classical Complement PathwaysDefective production of interleukin-6 in very small premature infants in response to bacterial pathogens.Cooperative complement- and bacterial lectin-initiated bactericidal activity of polymorphonuclear leukocytes.Influence of serotype of group B streptococci on C3 degradation.Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharideComplement and antibody participation in opsonophagocytosis of type IV and V group B streptococci.Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococciAntibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1Contributions of complement and immunoglobulin to neutrophil-mediated killing of enterococci.
P2860
Q28342811-3D7CDC93-4C91-475E-B4DA-57146ABE2E8FQ33614322-0C57036C-B3E7-4B55-855D-4F1DABB89051Q33703237-77AD655E-36D9-48CD-B218-A96BEE15D245Q33715970-8082ECCD-0A53-46B7-9523-8674C99BE020Q34000922-0BD8108B-64E4-47F8-9307-66EF453FE1B5Q35104769-9311ADFF-1AFA-4367-ADE3-8FBFDFE73DE0Q36344718-FCEB6F4D-3AB5-4D51-B783-9479CD4C555EQ36375663-E1C4D9C7-A181-4731-AF63-27C40C1FC6B7Q36382263-605EFF22-9561-4826-BB96-6EDCDB039F53Q36954959-D46A8CDD-32C6-45CD-8EAC-4E19F3CF4468Q36959461-F6C13C20-41EA-44BC-8B7E-C4AFFA70D36EQ36969922-02244AF4-9E6D-40E2-BF95-65C31C22D081Q36971152-1D225BB7-9946-476C-A2A2-7CA6C839E15CQ36972326-20B24D40-4928-4449-89EF-2FD30D311778Q37018919-F56E512A-F56D-4125-98BB-55282DC60989Q37050674-D3BD2CDE-0F01-40C4-B9B9-6BA7689CC9ABQ40147853-DF118AF1-E191-45C2-AD03-077946D45AAB
P2860
Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1982
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antibody-independent classical ...... ype Ia, group B streptococcus.
@en
Antibody-independent classical ...... ype Ia, group B streptococcus.
@nl
type
label
Antibody-independent classical ...... ype Ia, group B streptococcus.
@en
Antibody-independent classical ...... ype Ia, group B streptococcus.
@nl
prefLabel
Antibody-independent classical ...... ype Ia, group B streptococcus.
@en
Antibody-independent classical ...... ype Ia, group B streptococcus.
@nl
P2093
P2860
P356
P1476
Antibody-independent classical ...... ype Ia, group B streptococcus.
@en
P2093
P2860
P304
P356
10.1172/JCI110463
P407
P577
1982-02-01T00:00:00Z